These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7672494)

  • 1. Lipoprotein (a) and vascular disease in diabetic patients.
    James RW; Boemi M; Sirolla C; Amadio L; Fumelli P; Pometta D
    Diabetologia; 1995 Jun; 38(6):711-4. PubMed ID: 7672494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral atherosclerosis and serum lipoprotein(a) in diabetes.
    Wollesen F; Dahlén G; Berglund L; Berne C
    Diabetes Care; 1999 Jan; 22(1):93-8. PubMed ID: 10333909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Serum lipids in diabetes mellitus. Relation to equilibration and microangiopathy].
    Beylot M; Garcia I; Temori SA; Orgiazzi J; Revol A; Noel G
    Diabete Metab; 1983 Sep; 9(3):199-203. PubMed ID: 6653858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular complications in long-term south Indian NIDDM of over 25 years' duration.
    Mohan V; Vijayaprabha R; Rema M
    Diabetes Res Clin Pract; 1996 Mar; 31(1-3):133-40. PubMed ID: 8792113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid levels and peripheral vascular disease in diabetic and non-diabetic subjects.
    O'Neal DN; Lewicki J; Ansari MZ; Matthews PG; Best JD
    Atherosclerosis; 1998 Jan; 136(1):1-8. PubMed ID: 9544725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective study of lipoprotein(a) as a risk factor for atherosclerotic cardiovascular disease in patients with diabetes.
    Hiraga T; Kobayashi T; Okubo M; Nakanishi K; Sugimoto T; Ohashi Y; Murase T
    Diabetes Care; 1995 Feb; 18(2):241-4. PubMed ID: 7729305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum lipoprotein(a) is increased in hypertensive NIDDM patients.
    Hancu N; Netea MG; Iancu S
    Diabetes Care; 1995 Jun; 18(6):879-80. PubMed ID: 7555518
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma lipoprotein (a) levels in Turkish NIDDM patients with and without vascular diabetic complications.
    Erem C; Değer O; Bostan M; Orem A; Sönmez M; Ulusoy S; Telatar M
    Acta Cardiol; 1999 Aug; 54(4):203-7. PubMed ID: 10511896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein (a) and microvascular disease in type 1 (insulin-dependent) diabetes.
    Winocour PH; Bhatnagar D; Ishola M; Arrol S; Durrington PN
    Diabet Med; 1991 Dec; 8(10):922-7. PubMed ID: 1838043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein(a) and cardiovascular disease in type 2 (non-insulin-dependent) diabetic patients with and without diabetic nephropathy.
    Nielsen FS; Voldsgaard AI; Gall MA; Rossing P; Hommel E; Andersen P; Dyerberg J; Parving HH
    Diabetologia; 1993 May; 36(5):438-44. PubMed ID: 8314449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein(a) is an independent risk factor for peripheral arterial disease in Chinese type 2 diabetic patients in Taiwan.
    Tseng CH
    Diabetes Care; 2004 Feb; 27(2):517-21. PubMed ID: 14747238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atherosclerosis in carotid artery of young IDDM patients monitored by ultrasound high-resolution B-mode imaging.
    Yamasaki Y; Kawamori R; Matsushima H; Nishizawa H; Kodama M; Kajimoto Y; Morishima T; Kamada T
    Diabetes; 1994 May; 43(5):634-9. PubMed ID: 8168638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum lipoprotein(a) in patients with diabetes mellitus.
    Heller FR; Jamart J; Honore P; Derue G; Novik V; Galanti L; Parfonry A; Hondekijn JC; Buysschaert M
    Diabetes Care; 1993 May; 16(5):819-23. PubMed ID: 8495624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential influence of LDL cholesterol and triglycerides on lipoprotein(a) concentrations in diabetic patients.
    Hernández C; Chacón P; García-Pascual L; Simó R
    Diabetes Care; 2001 Feb; 24(2):350-5. PubMed ID: 11213891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoprotein(a) in diabetic patients with and without chronic renal failure.
    Guillausseau PJ; Peynet J; Chanson P; Legrand A; Altman JJ; Poupon J; N'Guyen M; Rousselet F; Lubetzki J
    Diabetes Care; 1992 Aug; 15(8):976-9. PubMed ID: 1387074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of macrovascular diseases in NIDDM patients in northern Taiwan. A 4-yr follow-up study.
    Fu CC; Chang CJ; Tseng CH; Chen MS; Kao CS; Wu TJ; Wu HP; Chuang LM; Chen CJ; Tai TY
    Diabetes Care; 1993 Jan; 16(1):137-43. PubMed ID: 8422768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lipoprotein(a) and plasminogen patients with diabetes mellitus complicated with peripheral angiopathy and hypertension].
    Sapian-Raczkowska B; Adamiec R; Zdrojowy K; Masłowski L
    Pol Merkur Lekarski; 2005 Jun; 18(108):634-6. PubMed ID: 16124372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperfibrinogenemia. An important risk factor for vascular complications in diabetes.
    Ganda OP; Arkin CF
    Diabetes Care; 1992 Oct; 15(10):1245-50. PubMed ID: 1425083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum lipids and lipoprotein(a) concentrations in Chinese NIDDM patients. Relation to metabolic control.
    Chang CJ; Kao JT; Wu TJ; Lu FH; Tai TY
    Diabetes Care; 1995 Aug; 18(8):1191-4. PubMed ID: 7587858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum lipoprotein(a) is not increased in NIDDM patients with microalbuminuria.
    Girelli A; Cimino A; Rocca L; Salvi A; Spandrio S; Valentini U; Guistina A
    Diabetes Care; 1994 May; 17(5):456-7. PubMed ID: 8062619
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.